- Investing Ideas
- /
- Norwegian Biotech Stocks
Norwegian Biotech Stocks
Results
9
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
9 companies
Photocure
Market Cap: NOK 1.9b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 71.90
7D
4.8%
1Y
22.9%
ArcticZymes Technologies
Market Cap: NOK 1.1b
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.
AZT
NOK 21.20
7D
-2.8%
1Y
50.8%
Vistin Pharma
Market Cap: NOK 904.6m
Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.
VISTN
NOK 20.40
7D
0%
1Y
-12.8%
Hofseth BioCare
Market Cap: NOK 663.5m
Produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States.
HBC
NOK 1.33
7D
-2.2%
1Y
-27.7%
Navamedic
Market Cap: NOK 551.6m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 23.00
7D
-0.4%
1Y
-11.2%
Norda
Market Cap: NOK 513.2m
A biotechnology company, engages in the cancer diagnostic activities.
NORD
NOK 100.00
7D
0%
1Y
n/a
Arctic Bioscience
Market Cap: NOK 98.7m
A clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific.
ABS
NOK 3.66
7D
13.0%
1Y
93.7%
EXACT Therapeutics
Market Cap: NOK 90.5m
A clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT).
EXTX
NOK 1.43
7D
-2.7%
1Y
-62.2%
PCI Biotech Holding
Market Cap: NOK 9.0m
A biopharmaceutical company, focuses on the development of technologies and novel therapies through its photochemical technology platform.
PCIB
NOK 0.24
7D
-3.2%
1Y
-82.6%